The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Creation and characterization of a novel human PDGFRA D842V-mutant GIST cell line.
 
Lillian Rose Klug
No Relationships to Disclose
 
Gleb Abalakov
No Relationships to Disclose
 
Diana Griffith
No Relationships to Disclose
 
Ajia Town
No Relationships to Disclose
 
Arin McKinley
No Relationships to Disclose
 
Susanne Grunewald
No Relationships to Disclose
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Lori Rink
No Relationships to Disclose
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD
Honoraria - Novartis
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; MolecularMD; Novartis; Pfizer
Research Funding - Blueprint Medicines (Inst); Deciphera (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis